A research group at LMU University Hospital has investigated how Alzheimer's disease can be diagnosed more reliably in the future.
CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding ...
CNSide identified extensive, actionable mutational changes, and clinically relevant longitudinal biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback